Wednesday, 1st April 2009
Hall 10, International Convention Centre, Birmingham

PROGRAMME
8.30 - 9.00	Registration and coffee
9.00 - 9.50	Owner's perceptions and priorities of quality and quantity of life in cats with heart disease Mark Oyama, University of Pennsylvania
9.50 - 10.40	Determinants of outcome in dogs with mitral valve regurgitation Adrian Boswood, RVC
10.40 - 11.10	Coffee
11.10 - 12.00	3D Echo Anne French, R(D)SVS
12.00 - 12.40	THE FORTEKOR STATE OF THE ART LECTURE Beyond furosemide: Use of torasemide in dogs with heart failure Mark Oyama, University of Pennsylvania
12.40 - 13.00	Levosimendan: a new therapy for congestive heart failure Piero Pollesello, Orion Pharmaceuticals
13.00 - 14.00	Lunch
14.00 - 15.00	Results of the CLEVET study: Levosimendan in canine CHF Mike Martin, Martin Referrals
15.10 - 15.25	Doppler-derived pulmonary hypertension on survival in a longitudinal study of MVD in dogs Melanie Hezzell, RVC
15.25 - 15.55	Coffee
15.55 - 16.40	Neutraceuticals in heart disease Dan Chan, RVC
16.40 - 17.00	Pulmonic stenosis in English bulldogs Speaker to be announced
17.00	Close